Post by Michigan Medicine

FIRST-IN-HUMAN: As part of a national clinical trial for patients with difficulty speaking, neurosurgeons at University of Michigan Health completed the first implantation of a Paradromics Inc., wireless brain-computer interface, or BCI. The study will focus on the device’s long-term safety, as well as assess whether the BCI can restore participants' communication through synthesized text and speech, and help them control a computer. “This has the potential to be a major step forward as we work toward our goal of helping treat people with paralysis who otherwise lack efficient and effective therapies for preserving communication,” said Dr. Matthew Willsey, who led the surgery. Click this link to learn more about the Connexus BCI implantation: https://michmed.org/zdV9Z